Discontinuation and nonpublication of osteosarcoma clinical trials: a cross-sectional analysis of ClinicalTrials.gov data
{{output}}
Background: Osteosarcoma is a rare and aggressive malignancy with limited therapeutic advances despite extensive clinical research. Discontinuation and failure to publish trial results contribute to research waste and may delay p... ...
